The Europe Bioabsorbable Stents Market generated revenue of $116 million in 2016. The market is expected to rapidly grow by the year 2025 to $328 million. Therefore, the Europe market for the bioabrosabable stent is anticipated to be the largest region in terms of market share by the end of the forecasting period. The CAGR during the forecasting years is estimated to be 12.14% and the base year deliberated for the analysis of the market is 2016.

EUROPE BIOABSORBABLE STENTS MARKET FORECAST 2017-2025

Europe bioabsorbable Stents Market by Absorption Rate (Slow Absorption Stents, Fast Absorption Stents) by Drugs (Paclitaxel, Limus Based Drugs) by Application (Coronary Artery Disease, Peripheral Artery Disease) by End Users (Hospitals, Cardiac Centers) by Materials (Polymeric Stents, Metallic Stents) & by Geography

Request free sample

Report Summary

The bioabsorbable stent Europe market generated revenue of $116 million in 2016. The market is expected to rapidly grow by the year 2025 to $328 million. Therefore, the Europe market for the bioabrosabable stent is anticipated to be the largest region in terms of market share by the end of the forecasting period. The CAGR during the forecasting years is estimated to be 12.14% and the base year deliberated for the analysis of the market is 2016. The forecasting years are from 2017 to 2025. Increase in the utilization of technologically developed products is the major driving factor up surging the development of the Europe bioabsorbable stent market.

The countries studied in the bioabsorbable stent market in the Europe region are France, United Kingdom, Spain, Germany, Italy, and Rest of Europe. Increased coronary and peripheral procedures is the key reason increasing the demand for bioabsorbable stents in the Europe region. Furthermore, increasing acceptance of MI surgeries with its excellent benefits is enhancing the growth of the market in this region.

Few of the established players of the bioabsorbable market present in the Europe region are Johnson & Johnson, Boston Scientific Corp, Abbott Laboratories, Arterial Remodeling Technologies, and Medtronic Inc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
RESEARCH METHODOLOGY
- SOURCES OF DATA
  - SECONDARY DATA
  - PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
  - BIOABSORBABLE STENTS ARE USED IN A WIDE RANGE OF APPLICATIONS
  - GROWING INCIDENCE OF CVDS
  - POLYMERIC STENTS MARKET IS ANTICIPATED TO GROW AT A FASTER RATE
  - CORONARY ARTERY DISEASE HOLDS THE LARGEST MARKET SHARE

MARKET DETERMINANTS
- MARKET DRIVERS
  - RISE IN INCIDENCE OF CARDIAC DISEASES
  - INCREASING RISK OF CORONARY ARTERY & PERIPHERAL ARTERY DISEASES IN THE ELDERLY POPULATION
  - INCREASING NUMBER OF HEART FAILURE AND DIABETES CASES
  - STRONG PRODUCT PIPELINES
  - RISING TECHNOLOGICAL ADVANCEMENTS
  - INCREASING DIABETIC POPULATION
- MARKET RESTRAINTS
  - SLOW ADOPTION RATE
  - STRINGENT GOVERNMENT REGULATIONS
  - HIGH COST OF DEVICES
- MARKET OPPORTUNITIES
  - RISING DEMAND FROM EMERGING ECONOMIES
  - TARGET HIGH-RISK PATIENTS
- MARKET CHALLENGES
  - AVAILABILITY OF SUBSTITUTE
  - INCREASING R&D ACTIVITIES FOR THE CELL TRANSPLANTATION TO TREAT THE HEART
  - STRINGENT GUIDELINE FOR AUTHORIZATION OF DEVICES
  - GROWING COMPETITION AMONG VENDORS

MARKET SEGMENTATION
- MARKET BY ABSORPTION RATE 2017-2025
  - SLOW ABSORPTION STENTS
  - FAST ABSORPTION STENTS
- MARKET BY DRUGS 2017-2025
  - PACLITAXEL
  - LIMUS BASED DRUGS
- MARKET BY APPLICATION 2017-2025
  - CORONARY ARTERY DISEASE
  - PERIPHERAL ARTERY DISEASE
- MARKET BY END USERS 2017-2025
  - HOSPITALS
  - CARDIAC CENTERS
- MARKET BY MATERIALS 2017-2025
  - POLYMERIC STENTS
  - METALLIC STENTS

KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
  - THREAT OF NEW ENTRANTS
  - THREAT OF SUBSTITUTES
  - BARGAINING POWER OF BUYERS
  - BARGAINING POWER OF SUPPLIERS
  - COMPETITIVE RIVALRY BETWEEN EXISTING PLAYERS
- MERGERS AND ACQUISITIONS
- OPPORTUNITY MATRIX
GEOGRAPHICAL ANALYSIS
- EUROPE
  - UNITED KINGDOM
  - FRANCE
  - GERMANY
  - SPAIN
  - ITALY
  - REST OF EUROPE

COMPANY PROFILE
- ABBOTT LABORATORIES
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- AMARANTH MEDICAL INC.
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- ARTERIAL REMODELING TECHNOLOGIES
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- ARTERIUS LIMITED
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- BOSTON SCIENTIFIC CORP.
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- ELIXIR MEDICAL CORPORATION
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- JOHNSON & JOHNSON
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- KYOTO MEDICAL PLANNING CO. LTD
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- MEDTRONIC INC
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- MERIL LIFE SCIENCES
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- SAHAJAN AND MEDICAL TECHNOLOGY
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- TEPHA INC
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- XENOGENICS CORPORATION (A SUBSIDIARY OF MULTICELL TECHNOLOGIES INC.)
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- STENTYS S.A.S.
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC ANALYSIS
  - SWOT ANALYSIS
- BIOABSORBABLE THERAPEUTICS, INC.
  - OVERVIEW
  - PRODUCT PORTFOLIO
  - SWOT ANALYSIS

TABLE LIST

TABLE 1 FACTS FOR THE HEART FAILURE

TABLE 2 FACT FOR THE DIABETES CASES

TABLE 3 LIST OF SOME OF THE BIOABSORBABLE STENTS THAT ARE CURRENTLY UNDER TRIALS

TABLE 4 AVAILABLE BIORESORBABLE SCAFFOLDS

TABLE 5 EUROPE BIOABSORBABLE STENTS MARKET, BY ABSORPTION RATE 2017-2025 ($ MILLION)

TABLE 6 EUROPE BIOABSORBABLE STENTS MARKET IN SLOW ABSORPTION RATE, 2017-2025 ($ MILLION)

TABLE 7 EUROPE BIOABSORBABLE STENTS MARKET IN FAST ABSORPTION RATE, 2017-2025 ($ MILLION)

TABLE 8 EUROPE BIOABSORBABLE STENTS MARKET IN DRUGS, 2017-2025 ($ MILLION)

TABLE 9 EUROPE BIOABSORBABLE STENTS MARKET IN PACLITAXEL, 2017-2025 ($ MILLION)

TABLE 10 EUROPE BIOABSORBABLE STENTS MARKET SHARE IN LIMUS BASED DRUGS, 2017-2025 ($ MILLION)

TABLE 11 EUROPE BIOABSORBABLE STENTS MARKET, BY APPLICATIONS 2017-2025 ($ MILLION)

TABLE 12 EUROPE BIOABSORBABLE STENTS MARKET IN CORONARY ARTERY DISEASE, 2017-2025 ($ MILLION)

TABLE 13 EUROPE BIOABSORBABLE STENTS MARKET IN PERIPHERAL ARTERY DISEASE, 2017-2025 ($ MILLION)

TABLE 14 LIST OF COUNTRIES BY ANNUAL PER CAPITA CONSUMPTION OF TOBACCO CIGARETTES IN 2015

TABLE 15 EUROPE BIOABSORBABLE STENTS MARKET, BY END USERS 2017-2025 ($ MILLION)

TABLE 16 EUROPE BIOABSORBABLE STENTS MARKET IN HOSPITALS, 2017-2025 ($ MILLION)

TABLE 17 EUROPE BIOABSORBABLE STENTS MARKET IN CARDIAC CENTERS, 2017-2025 ($ MILLION)

TABLE 18 EUROPE BIOABSORBABLE STENTS MARKET, BY MATERIALS 2017-2025 ($ MILLION)

TABLE 19 EUROPE BIOABSORBABLE STENTS MARKET IN POLYMERIC STENTS, 2017-2025 ($ MILLION)

TABLE 20 EUROPE BIOABSORBABLE STENTS MARKET SHARE IN METALLIC STENTS, 2017-2025 ($ MILLION)

FIGURE LIST

FIGURE 1 EUROPE BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

FIGURE 2 PREVALENCE OF PAD (%) BY AGE GROUP (YEARS)

FIGURE 3 EUROPE BIOABSORBABLE STENTS MARKET IN SLOW ABSORPTION RATE, 2017-2025($ MILLION)

FIGURE 4 EUROPE BIOABSORBABLE STENTS MARKET IN FAST ABSORPTION RATE, 2017-2025($ MILLION)

FIGURE 5 EUROPE BIOABSORBABLE STENTS MARKET IN PACLITAXEL, 2017-2025 ($ MILLION)

FIGURE 6 EUROPE BIOABSORBABLE STENTS MARKET IN LIMUS BASED DRUGS 2017-2025 ($ MILLION)

FIGURE 7 EUROPE BIOABSORBABLE STENTS MARKET IN CORONARY ARTERY DISEASE, 2017-2025 ($ MILLION)

FIGURE 8 EUROPE BIOABSORBABLE STENTS MARKET IN PERIPHERAL ARTERY DISEASE, 2017-2025

FIGURE 9 EUROPE BIOABSORBABLE STENTS MARKET IN HOSPITALS 2017-2025 ($ MILLION)

FIGURE 10 EUROPE BIOABSORBABLE STENTS MARKET SHARE IN CARDIAC CENTERS 2017-2025 ($ MILLION)

FIGURE 11 EUROPE BIOABSORBABLE STENTS MARKET IN POLYMERIC STENTS 2017-2025 ($ MILLION)

FIGURE 12 EUROPE BIOABSORBABLE STENTS MARKET SHARE IN METALLIC STENTS 2017-2025 ($ MILLION)

FIGURE 13 EUROPE BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

FIGURE 14 UNITED KINGDOM BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

FIGURE 15 FRANCE BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

FIGURE 16 GERMANY BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

FIGURE 17 SPAIN BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

FIGURE 18 ITALY BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

FIGURE 19 REST OF EUROPE BIOABSORBABLE STENTS MARKET 2017-2025 ($ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- EUROPE
  - UNITED KINGDOM
  - FRANCE
  - GERMANY
  - SPAIN
  - ITALY
  - REST OF EUROPE

MARKET SEGMENTATION
- MARKET BY ABSORPTION RATE 2017-2025
  - SLOW ABSORPTION STENTS
  - FAST ABSORPTION STENTS
- MARKET BY DRUGS 2017-2025
  - PACLITAXEL
  - LIMUS BASED DRUGS
- MARKET BY APPLICATION 2017-2025
  - CORONARY ARTERY DISEASE
  - PERIPHERAL ARTERY DISEASE
- MARKET BY END USERS 2017-2025
  - HOSPITALS
  - CARDIAC CENTERS
- MARKET BY MATERIALS 2017-2025
  - POLYMERIC STENTS
  - METALLIC STENTS

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.